Study of Essential Oils and Probiotics to Improve Intestinal Health in Adults with Acute Coronary Syndrome ACS Aged 30 to 70

What this Trial Is About

This research aims to study patients diagnosed with acute coronary syndromes ACS, including unstable coronary artery disease and acute myocardial infarction. The study evaluates whether specially formulated essential oils with high bioavailability can restore healthy intestinal balance after two months, confirmed through specific laboratory tests such as metabolomics. It focuses on intestinal permeability and dysbiosis indices at baseline and after 24 hours in affected patients. Participants will receive conventional drug therapy prescribed by their medical examiner along with non-pharmacological treatment consisting of essential oils and probiotic and prebiotic components taken as two capsules daily for two months. The study includes an initial visit for sample collection and assessments, followed by continuous treatment and a second visit after two months for further urine sampling and metabolomic analysis. During the study, participants will visit the experimental center at baseline for demographic data collection, blood and multiple urine samples at specific intervals 0, 6, 12, and 24 hours. After two months of combined therapy, they return for a follow-up urine sample to complete metabolomics and intestinal dysbiosis data. Researchers will monitor metabolic cardiovascular risk and urinary metabolites throughout approximately one year and will record any adverse events during treatment, especially those causing treatment to stop.

Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.